Affymetrix to Commercialize Powerful Genotyping Array for Chinese Population

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will develop and commercialize the Axiom(TM) Chinese myDesign(TM) Genotyping Array, the first product that provides maximum power for genome-wide association studies (GWAS) specifically on Chinese populations.

Source: Affymetrix